Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Report: Trends, Forecast and Competitive Analysis to 2030

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Trends and Forecast

The future of the global enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets. The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are growing prevalance of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others and growing geriatric population who are at a risk of developing several infections.

A more than 150-page report is developed to help in your business decisions.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests by Segment

The study includes a forecast for the global enzyme-linked immunosorbent assay (ELISA) tests by type, application, end use, and region.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Sandwich ELISA
• Indirect ELISA
• Multiple and Portable ELISA
• Competitive ELISA

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Immunology
• Vaccine Development
• Infectious Diseases
• Cancer
• Protein Quantitation
• Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotech Companies
• Academic Research Centers
• Clinical Laboratories
• Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Enzyme-Linked Immunosorbent Assay (ELISA) Tests Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies enzyme-linked immunosorbent assay (ELISA) tests companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the enzyme-linked immunosorbent assay (ELISA) tests companies profiled in this report include-

• Ortho Clinical Diagnostics
• Thermo Fisher Scientific
• Biomerieux
• Sysmex Corporation
• F. Hoffmann-La Roche
• Danaher Corporation
• Quidel Corporation
• Bio-Rad Laboratories
• Siemens Healthineers
• Abbott Laboratories

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Insights

Lucintel forecasts that multiple and portable ELISA is expected to witness highest growth over the forecast period due to portability and on-going technological advancements.

Within this market, hospitals and diagnostic centers will remain the largest segment due to the increasing prevalence of diseases, rising demand for personalized medicine, and growing government support for ELISA testing.

North America will remain the largest region over the forecast period due to surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Features of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Market Size Estimates: Enzyme-linked immunosorbent assay (ELISA) tests market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the enzyme-linked immunosorbent assay (ELISA) tests market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the enzyme-linked immunosorbent assay (ELISA) tests market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The major drivers for this market are growing prevalance of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others and growing geriatric population who are at a risk of developing several infections.

Q3. What are the major segments for enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The future of the enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets.

Q4. Who are the key enzyme-linked immunosorbent assay (ELISA) tests market companies?

Answer: Some of the key enzyme-linked immunosorbent assay (ELISA) tests companies are as follows:

• Ortho Clinical Diagnostics
• Thermo Fisher Scientific
• Biomerieux
• Sysmex Corporation
• F. Hoffmann-La Roche
• Danaher Corporation
• Quidel Corporation
• Bio-Rad Laboratories
• Siemens Healthineers
• Abbott Laboratories

Q5. Which enzyme-linked immunosorbent assay (ELISA) tests market segment will be the largest in future?

Answer: Lucintel forecasts that multiple and portable ELISA is expected to witness highest growth over the forecast period due to portability and on-going technological advancements.

Q6. In enzyme-linked immunosorbent assay (ELISA) tests market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the enzyme-linked immunosorbent assay (ELISA) tests market by type (sandwich ELISA, indirect ELISA, multiple and portable ELISA, and competitive ELISA), application (immunology, vaccine development, infectious diseases, cancer, protein quantitation, and others), end use (hospitals and diagnostic centers, pharmaceutical and biotech companies, academic research centers, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?